The Manila Times

AIM's Iterative Process High-Efficiency Diploid Rabies Vaccine Completes Phase III Clinical Trials, Efficacy Significantly Higher than Existing Market Products

AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully ...
STAT

U.S. health officials inject new uncertainty into approval process for Covid boosters

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...
National Academies of Sciences%2c Engineering%2c and Medicine

The Search for a COVID-19 Vaccine — ‘There’s No One Winner’

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
BW Businessworld

Dedicated Vaccine Portal and National Clinical Registry of COVID-19 launched

Dr. Harsh Vardhan, Union Minister for Health & Family Welfare, Government of India launched the vaccine portal for COVID-19 and National Clinical Registry for COVID-19 today developed by ICMR. Dr.

Cedar fever cure? Researchers developing vaccine for severe allergies

Researchers at Penn Medicine have developed an mRNA vaccine that could potentially cure allergies by stopping allergens from ...